These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 39329952)

  • 1. Disulfidptosis: A New Target for Parkinson's Disease and Cancer.
    Liu T; Kong X; Wei J
    Curr Issues Mol Biol; 2024 Sep; 46(9):10038-10064. PubMed ID: 39329952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pan-cancer genetic analysis of disulfidptosis-related gene set.
    Liu H; Tang T
    Cancer Genet; 2023 Nov; 278-279():91-103. PubMed ID: 37879141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of disulfidptosis-associated genes and characterization of immune cell infiltration in thyroid carcinoma.
    Song S; Zhou J; Zhang L; Sun Y; Zhang Q; Tan Y; Zhou X; Yu J
    Aging (Albany NY); 2024 Jun; 16(11):9753-9783. PubMed ID: 38836761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disulfidptosis-related gene expression reflects the prognosis of drug-resistant cancer patients and inhibition of MYH9 reverses sorafenib resistance.
    Zhang K; Zhu Z; Zhou J; Shi M; Wang N; Yu F; Xu L
    Transl Oncol; 2024 Nov; 49():102091. PubMed ID: 39146597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated Bioinformatic Analysis and Validation Identifies Immune Microenvironment-Related Potential Biomarkers in Alzheimer's Disease.
    Yang F; Zhang N; Ou GY; Xu SW
    J Prev Alzheimers Dis; 2024; 11(2):495-506. PubMed ID: 38374756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and verification of disulfidptosis-related genes in sepsis-induced acute lung injury.
    Zhang A; Wang X; Lin W; Zhu H; Pan J
    Front Med (Lausanne); 2024; 11():1430252. PubMed ID: 39262873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pan-cancer and single-cell analysis of actin cytoskeleton genes related to disulfidptosis.
    Shen LP; Jiang HT
    Open Med (Wars); 2024; 19(1):20240929. PubMed ID: 38584831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unveiling the role of disulfidptosis-related genes in the pathogenesis of non-alcoholic fatty liver disease.
    Luo X; Guo J; Deng H; He Z; Wen Y; Si Z; Li J
    Front Immunol; 2024; 15():1386905. PubMed ID: 38812509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel disulfidptosis-related prognostic gene signature and experimental validation identify ACTN4 as a novel therapeutic target in lung adenocarcinoma.
    Xie K; Wang B; Pang P; Li G; Yang Q; Fang C; Jiang W; Feng Y; Ma H
    Cancer Biomark; 2024 Feb; ():. PubMed ID: 38517776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiomics Analysis of Disulfidptosis Patterns and Integrated Machine Learning to Predict Immunotherapy Response in Lung Adenocarcinoma.
    Liu J; Li H; Zhang N; Dong Q; Liang Z
    Curr Med Chem; 2024; 31(25):4034-4055. PubMed ID: 38685772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of disulfidptosis-related genes and subgroups in Alzheimer's disease.
    Ma S; Wang D; Xie D
    Front Aging Neurosci; 2023; 15():1236490. PubMed ID: 37600517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
    Wang N; Zhu L; Wang L; Shen Z; Huang X
    Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson's Disease as a Risk Factor for Prostate Adenocarcinoma: A Molecular Point of View.
    Liu T; Yang Z; Liu S; Wei J
    Gerontology; 2023; 69(8):986-1001. PubMed ID: 36921580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Construction and Validation of a Novel Ferroptosis-Related Gene Signature in Parkinson's Disease.
    Liu T; Wu H; Wei J
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139032
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Wang X; Zhu HQ; Lin SM; Xia BY; Xu B
    Transl Cancer Res; 2024 May; 13(5):2518-2534. PubMed ID: 38881923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of disulfidptosis-based immune response prediction model with artificial intelligence and validation of the pivotal grouping oncogene c-MET in regulating T cell exhaustion.
    Li P; Wang S; Wan H; Huang Y; Yin K; Sun K; Jin H; Wang Z
    Front Immunol; 2024; 15():1258475. PubMed ID: 38352883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pan-Cancer Integrated Analysis Identification of SASH3, a Potential Biomarker That Inhibits Lung Adenocarcinoma Progression.
    Chen X; Yuan Y; Ren W; Zhou F; Huang X; Pu J; Niu X; Jiang X
    Front Oncol; 2022; 12():927988. PubMed ID: 35756681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Analysis and Experimental Validation of the Parkinson's Disease Lysosomal Gene ACP2 and Pan-cancer.
    Liang Y; Zhong G; Li Y; Ren M; Wang A; Ying M; Liu C; Guo Y; Zhang D
    Biochem Genet; 2024 Dec; 62(6):4408-4431. PubMed ID: 38310198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying the hub gene and immune infiltration of Parkinson's disease using bioinformatical methods.
    Liu SH; Wang YL; Jiang SM; Wan XJ; Yan JH; Liu CF
    Brain Res; 2022 Jun; 1785():147879. PubMed ID: 35278479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative analysis of potential biomarkers and immune cell infiltration in Parkinson's disease.
    Chen X; Cao W; Zhuang Y; Chen S; Li X
    Brain Res Bull; 2021 Dec; 177():53-63. PubMed ID: 34536521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.